Alterations in normal liver doses due to organ motion.

PURPOSE To assess the clinical significance of differences between treatment planning calculations based on static computed tomography (CT) and more realistic predictions of the actual delivered dose to intrahepatic lesions by a geometric convolution approach that accounts for random setup variations and breathing-induced organ motion. MATERIALS AND METHODS We recalculated target and normal liver doses for 40 patients previously treated on a conformal therapy dose escalation protocol to include the effect of setup uncertainties and liver motion due to patient breathing. Initial three-dimensional (3D) dose calculations based on pretreatment CT scans taken with voluntary breath-hold at normal exhalation were convolved with 3D anisotropic probability distribution functions reflecting population measurements of position setup variation. The convolution also included a distribution function (one-dimensional, inferior-superior direction only) representing the asymmetric temporal pattern (biased toward exhalation, based on population measurements) of a typical breathing cycle, scaled in amplitude for each patient. RESULTS After convolution, the minimum clinical target volume (CTV) dose met or exceeded the minimum planning target volume (PTV) dose from the static plan in all but one case, indicating adequate PTV design. However, clinically relevant and statistically significant increases (decreases) in liver normal tissue complication probability (NTCP) from values computed for the static cases occurred for tumors located toward the bottom (top) of the liver, as predicted for these patients scanned at exhalation. The change in liver NTCP (from a nominal 20%) ranged from +12.0% to -11.7% (average magnitude change 3.9% [sigma = 3.3%]). Changes in prescription dose required to restore the original 20% NTCP ranged from -3.7 Gy to +7.9 Gy (average magnitude change 1.9 Gy [sigma = 1.9 Gy]). CONCLUSIONS Although the PTV concept can ensure adequate CTV coverage, the doses to normal liver are incorrectly modeled without including patient-related geometric uncertainties.

[1]  J M Balter,et al.  Quantization of setup uncertainties in 3-D dose calculations. , 1999, Medical physics.

[2]  Randall K Ten Haken,et al.  A method for incorporating organ motion due to breathing into 3D dose calculations in the liver: sensitivity to variations in motion. , 2003, Medical physics.

[3]  M. Martel,et al.  Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[4]  D L McShan,et al.  Inclusion of organ deformation in dose calculations. , 2003, Medical physics.

[5]  Y Seppenwoolde,et al.  Partial irradiation of the lung. , 2001, Seminars in radiation oncology.

[6]  Icru Prescribing, recording, and reporting photon beam therapy , 1993 .

[7]  R K Ten Haken,et al.  The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[8]  R K Ten Haken,et al.  Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Wong,et al.  The use of active breathing control (ABC) to reduce margin for breathing motion. , 1999, International journal of radiation oncology, biology, physics.

[10]  J. Leong,et al.  Implementation of random positioning error in computerised radiation treatment planning systems as a result of fractionation. , 1987, Physics in medicine and biology.

[11]  J. Lyman Complication Probability as Assessed from Dose-Volume Histograms , 1985 .

[12]  Daniel Normolle,et al.  Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.

[13]  R. T. Ten Haken,et al.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Marc L. Kessler,et al.  The use of 3-D dose volume analysis to predict radiation hepatitis. , 1991 .

[15]  Indrin J Chetty,et al.  A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: a Monte Carlo study. , 2003, Medical physics.

[16]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[17]  J M Balter,et al.  Technical note: creating a four-dimensional model of the liver using finite element analysis. , 2002, Medical physics.

[18]  R. T. Ten Haken,et al.  Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  K L Lam,et al.  Measurement of patient setup errors using port films and a computer-aided graphical alignment tool. , 1996, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[20]  J M Balter,et al.  Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors. , 1997, International journal of radiation oncology, biology, physics.

[21]  R K Ten Haken,et al.  Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. , 1991, International journal of radiation oncology, biology, physics.

[22]  James M Balter,et al.  Daily targeting of intrahepatic tumors for radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[23]  R K ten Haken,et al.  An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. , 1990, International journal of radiation oncology, biology, physics.

[24]  E. Larsen,et al.  A method for incorporating organ motion due to breathing into 3D dose calculations. , 1999, Medical physics.

[25]  M. Kessler,et al.  Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  K. Lam,et al.  Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging. , 1998, International journal of radiation oncology, biology, physics.

[27]  R K Ten Haken,et al.  Use of Veff and iso-NTCP in the implementation of dose escalation protocols. , 1993, International journal of radiation oncology, biology, physics.

[28]  R K Ten Haken,et al.  Partial irradiation of the liver. , 2001, Seminars in radiation oncology.

[29]  P J Keall,et al.  A method to predict the effect of organ motion and set-up variations on treatment plans. , 1999, Australasian physical & engineering sciences in medicine.

[30]  D L McShan,et al.  Technical considerations in the use of 3-D beam arrangements in the abdomen. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.